Current age | Catch-up regimen |
<6 months | Up to three doses of PRP-T* or two doses of PRP-OMP ≥4 weeks apart before age 12 months and one dose of Hib conjugate vaccine at 12 through 15 months of age at least 8 weeks after the previous dose |
7 through 11 months | Up to two doses of PRP-T* or PRP-OMP ≥4 weeks apart before age 12 months and one dose of Hib conjugate vaccine at 12 through 60 months of age at least 8 weeks after the previous dose |
12 through 14 months | Two doses of Hib conjugate vaccine ≥8 weeks apart, up to 60 months of age |
15 through 59 months | Single dose of Hib conjugate vaccine up to 60 months of age |
PRP-T: polyribosylribitol phosphate conjugated to tetanus toxoid; PRP-OMP: polyribosylribitol phosphate conjugated to the outer membrane protein complex of Neisseria meningitides; DTaP: diphtheria tetanus-toxoid-acellular pertussis vaccine; IPV: inactivated polio vaccine.
* PRP-T Hib conjugate vaccines approved for this age group include ActHIB, Hiberix, and DTaP-IPV/Hib.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟